Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123726179 | 12372617 | 9 | F | 20160427 | 20160808 | 20160516 | 20160816 | EXP | IT-ALEXION PHARMACEUTICALS INC-A201603426 | ALEXION | 15.26 | YR | F | Y | 0.00000 | 20160816 | CN | IT | IT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 123726179 | 12372617 | 1 | PS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | 600 MG, UNK | 125166 | 600 | MG | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||
| 123726179 | 12372617 | 2 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | UNK | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 123726179 | 12372617 | 3 | SS | SOLIRIS | ECULIZUMAB | 1 | Intravenous (not otherwise specified) | HALF VIAL EVERY 3 DAYS | 125166 | CONCENTRATE FOR SOLUTION FOR INFUSION | |||||||||
| 123726179 | 12372617 | 4 | C | METILPREDNISOLONE | METHYLPREDNISOLONE | 1 | Unknown | 12.5 MG, QD | 0 | 12.5 | MG | QD | |||||||
| 123726179 | 12372617 | 5 | C | METILPREDNISOLONE | METHYLPREDNISOLONE | 1 | Unknown | 2 MG/KG, UNK | 0 | 2 | MG/KG | ||||||||
| 123726179 | 12372617 | 6 | C | NEBIVOLOL. | NEBIVOLOL | 1 | Unknown | UNK | 0 | ||||||||||
| 123726179 | 12372617 | 7 | C | RAMIPRIL. | RAMIPRIL | 1 | Unknown | UNK | 0 | ||||||||||
| 123726179 | 12372617 | 8 | C | IDROCLOROTIAZIDE W/RAMIPRIL | HYDROCHLOROTHIAZIDERAMIPRIL | 1 | Unknown | UNK | 0 | ||||||||||
| 123726179 | 12372617 | 9 | C | NIFEDIPINE. | NIFEDIPINE | 1 | Unknown | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 123726179 | 12372617 | 1 | Haemolytic uraemic syndrome |
| 123726179 | 12372617 | 4 | Hypertension |
| 123726179 | 12372617 | 6 | Hypertension |
| 123726179 | 12372617 | 7 | Hypertension |
| 123726179 | 12372617 | 8 | Hypertension |
| 123726179 | 12372617 | 9 | Hypertension |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 123726179 | 12372617 | OT |
| 123726179 | 12372617 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 123726179 | 12372617 | Acute pulmonary oedema | |
| 123726179 | 12372617 | Alveolitis | |
| 123726179 | 12372617 | Blood pressure decreased | |
| 123726179 | 12372617 | Condition aggravated | |
| 123726179 | 12372617 | Hypertension | |
| 123726179 | 12372617 | Inappropriate schedule of drug administration | |
| 123726179 | 12372617 | Incorrect drug administration duration | |
| 123726179 | 12372617 | Pulmonary oedema | |
| 123726179 | 12372617 | Seizure | |
| 123726179 | 12372617 | Thrombotic microangiopathy |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 123726179 | 12372617 | 1 | 20160427 | 0 | ||
| 123726179 | 12372617 | 3 | 201607 | 0 | ||
| 123726179 | 12372617 | 9 | 20160427 | 0 |